Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Werewolf Therapeutics (HOWL) Enterprise Value (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Enterprise Value for 5 consecutive years, with -$57.1 million as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 48.56% to -$57.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$57.1 million through Dec 2025, up 48.56% year-over-year, with the annual reading at -$57.1 million for FY2025, 48.56% up from the prior year.
  • Enterprise Value for Q4 2025 was -$57.1 million at Werewolf Therapeutics, up from -$65.7 million in the prior quarter.
  • The five-year high for Enterprise Value was -$57.1 million in Q4 2025, with the low at -$183.2 million in Q2 2021.
  • Average Enterprise Value over 5 years is -$125.3 million, with a median of -$134.8 million recorded in 2023.
  • The sharpest move saw Enterprise Value crashed 69.87% in 2022, then surged 48.56% in 2025.
  • Over 5 years, Enterprise Value stood at -$157.5 million in 2021, then rose by 17.91% to -$129.3 million in 2022, then fell by 3.89% to -$134.3 million in 2023, then increased by 17.38% to -$111.0 million in 2024, then soared by 48.56% to -$57.1 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$57.1 million, -$65.7 million, and -$77.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.